{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-043670","form_type":"8-K","ticker":"VYNE","cik":"0001566044","company_name":"VYNE Therapeutics Inc.","filed_at":"2022-04-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.228545+00:00","generated_at":"2026-06-26T08:47:57.125289+00:00","sec_items":["4.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"VYNE reports positive Phase 1b data for FMX114 in atopic dermatitis; appoints Baker Tilly as auditor after PwC dismissal","bullets":["FMX114 showed statistically significant reduction in ADSI score at week 2: -81.4% mean reduction vs -54.3% for vehicle (p=0.004).","Pruritus reduced 96.4% mean from baseline for FMX114 vs 45.8% for vehicle at week 2.","Phase 2a safety and efficacy results expected in Q2 2022.","Audit committee dismissed PwC as auditor effective April 6, 2022; appointed Baker Tilly US, LLP as new auditor.","PwC's 2021 report included going concern explanatory paragraph due to incurred losses and negative cash flows."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-043670","json":"https://secwatch.observer/filing/0001104659-22-043670.json","markdown":"https://secwatch.observer/filing/0001104659-22-043670.md","text":"https://secwatch.observer/filing/0001104659-22-043670.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1566044/000110465922043670/0001104659-22-043670-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1566044/000110465922043670/tm228420d7_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T08:47:57.125289+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}